

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.93454937 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.93454937 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 7.93454937 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 7.93454937 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 7.93454937 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.93454937 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.94490657 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.87743955 |
| 9 | microglial cell activation (GO:0001774) | 6.26574429 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 5.93028338 |
| 11 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.48652481 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 5.47806390 |
| 13 | positive regulation of interferon-alpha production (GO:0032727) | 5.46499718 |
| 14 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 5.20473793 |
| 15 | response to host immune response (GO:0052572) | 5.20473793 |
| 16 | regulation of interferon-alpha production (GO:0032647) | 5.20304785 |
| 17 | macrophage activation (GO:0042116) | 4.96351855 |
| 18 | response to peptidoglycan (GO:0032494) | 4.79231008 |
| 19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.74439821 |
| 20 | response to host (GO:0075136) | 4.70685831 |
| 21 | response to host defenses (GO:0052200) | 4.70685831 |
| 22 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.70685831 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 4.61837695 |
| 24 | positive regulation of antigen processing and presentation (GO:0002579) | 4.51391517 |
| 25 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.42082326 |
| 26 | respiratory burst (GO:0045730) | 4.34298604 |
| 27 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.33353408 |
| 28 | myeloid cell activation involved in immune response (GO:0002275) | 4.23936940 |
| 29 | pinocytosis (GO:0006907) | 4.22532323 |
| 30 | detection of other organism (GO:0098543) | 4.07703232 |
| 31 | regulation of antigen processing and presentation (GO:0002577) | 3.85691752 |
| 32 | I-kappaB phosphorylation (GO:0007252) | 3.84498011 |
| 33 | detection of external biotic stimulus (GO:0098581) | 3.83458649 |
| 34 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.83349502 |
| 35 | positive regulation of interferon-beta production (GO:0032728) | 3.78742528 |
| 36 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.77394521 |
| 37 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.76566457 |
| 38 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.70100321 |
| 39 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.65785104 |
| 40 | detection of bacterium (GO:0016045) | 3.64658121 |
| 41 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.63145390 |
| 42 | cellular extravasation (GO:0045123) | 3.61980574 |
| 43 | T-helper 1 type immune response (GO:0042088) | 3.61768324 |
| 44 | negative regulation of interleukin-17 production (GO:0032700) | 3.60708652 |
| 45 | regulation of T cell tolerance induction (GO:0002664) | 3.52355930 |
| 46 | detection of molecule of bacterial origin (GO:0032490) | 3.51907711 |
| 47 | neutrophil activation (GO:0042119) | 3.51570985 |
| 48 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.51532559 |
| 49 | granulocyte activation (GO:0036230) | 3.51122173 |
| 50 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.49098415 |
| 51 | positive regulation of mast cell activation (GO:0033005) | 3.47836685 |
| 52 | detection of biotic stimulus (GO:0009595) | 3.46896889 |
| 53 | lymphocyte chemotaxis (GO:0048247) | 3.45876508 |
| 54 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.45563641 |
| 55 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.45412771 |
| 56 | positive regulation of macrophage cytokine production (GO:0060907) | 3.42886136 |
| 57 | regulation of tolerance induction (GO:0002643) | 3.40699110 |
| 58 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.40002591 |
| 59 | negative regulation of mast cell activation (GO:0033004) | 3.37718071 |
| 60 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.35839426 |
| 61 | regulation of mast cell degranulation (GO:0043304) | 3.32835351 |
| 62 | regulation of gamma-delta T cell activation (GO:0046643) | 3.32588431 |
| 63 | monocyte chemotaxis (GO:0002548) | 3.31283912 |
| 64 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.31119337 |
| 65 | amino sugar catabolic process (GO:0046348) | 3.31050626 |
| 66 | positive regulation of type 2 immune response (GO:0002830) | 3.26250623 |
| 67 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.25642970 |
| 68 | B cell mediated immunity (GO:0019724) | 3.22095779 |
| 69 | regulation of mast cell activation (GO:0033003) | 3.21817117 |
| 70 | myeloid leukocyte activation (GO:0002274) | 3.21746868 |
| 71 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.21718833 |
| 72 | positive regulation of lymphocyte migration (GO:2000403) | 3.19535250 |
| 73 | regulation of cholesterol storage (GO:0010885) | 3.19071940 |
| 74 | * regulation of mononuclear cell migration (GO:0071675) | 3.18501633 |
| 75 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.18297396 |
| 76 | phagocytosis, engulfment (GO:0006911) | 3.16140487 |
| 77 | eosinophil migration (GO:0072677) | 3.14288635 |
| 78 | germinal center formation (GO:0002467) | 3.13696562 |
| 79 | positive regulation of T cell migration (GO:2000406) | 3.13163022 |
| 80 | regulation of hypersensitivity (GO:0002883) | 3.09438974 |
| 81 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.09362058 |
| 82 | negative regulation of granulocyte differentiation (GO:0030853) | 3.08349007 |
| 83 | positive regulation of leukocyte degranulation (GO:0043302) | 3.04778504 |
| 84 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.04306871 |
| 85 | neutrophil mediated immunity (GO:0002446) | 3.03024038 |
| 86 | positive regulation of mast cell degranulation (GO:0043306) | 3.02883114 |
| 87 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.02883114 |
| 88 | regulation of leukocyte degranulation (GO:0043300) | 3.01470713 |
| 89 | glycolipid catabolic process (GO:0019377) | 2.97786450 |
| 90 | response to muramyl dipeptide (GO:0032495) | 2.97574330 |
| 91 | regulation of monocyte chemotaxis (GO:0090025) | 2.96807508 |
| 92 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.95780971 |
| 93 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.95131789 |
| 94 | mast cell activation (GO:0045576) | 2.94813295 |
| 95 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.94531970 |
| 96 | myeloid dendritic cell differentiation (GO:0043011) | 2.94499939 |
| 97 | response to thyroid hormone (GO:0097066) | 2.93105386 |
| 98 | defense response to protozoan (GO:0042832) | 2.92990860 |
| 99 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.92369369 |
| 100 | response to interferon-alpha (GO:0035455) | 2.92068245 |
| 101 | positive regulation of B cell differentiation (GO:0045579) | 2.91629563 |
| 102 | leukocyte aggregation (GO:0070486) | 2.91487101 |
| 103 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.90236524 |
| 104 | N-acetylneuraminate metabolic process (GO:0006054) | 2.89774890 |
| 105 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.88550953 |
| 106 | response to lipoprotein particle (GO:0055094) | 2.88358900 |
| 107 | natural killer cell mediated immunity (GO:0002228) | 2.88259617 |
| 108 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.88259617 |
| 109 | oligosaccharide catabolic process (GO:0009313) | 2.88242339 |
| 110 | hyaluronan catabolic process (GO:0030214) | 2.87585720 |
| 111 | eosinophil chemotaxis (GO:0048245) | 2.87537512 |
| 112 | granulocyte chemotaxis (GO:0071621) | 2.87104749 |
| 113 | NIK/NF-kappaB signaling (GO:0038061) | 2.87006619 |
| 114 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.85590199 |
| 115 | negative regulation of interleukin-12 production (GO:0032695) | 2.85517305 |
| 116 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.84366367 |
| 117 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.84306643 |
| 118 | cellular response to interferon-gamma (GO:0071346) | 2.83892858 |
| 119 | type I interferon signaling pathway (GO:0060337) | 2.83330339 |
| 120 | cellular response to type I interferon (GO:0071357) | 2.83330339 |
| 121 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.81849911 |
| 122 | neutrophil migration (GO:1990266) | 2.81769448 |
| 123 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.81469858 |
| 124 | positive regulation of chemokine production (GO:0032722) | 2.81096900 |
| 125 | B cell receptor signaling pathway (GO:0050853) | 2.80875182 |
| 126 | response to type I interferon (GO:0034340) | 2.79854361 |
| 127 | negative regulation of cell killing (GO:0031342) | 2.79158794 |
| 128 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.79158794 |
| 129 | regulation of interferon-beta production (GO:0032648) | 2.78461621 |
| 130 | neutrophil chemotaxis (GO:0030593) | 2.76406543 |
| 131 | cell adhesion mediated by integrin (GO:0033627) | 2.75591359 |
| 132 | lymphocyte mediated immunity (GO:0002449) | 2.75307362 |
| 133 | regulation of lymphocyte migration (GO:2000401) | 2.75180395 |
| 134 | leukocyte mediated cytotoxicity (GO:0001909) | 2.73614199 |
| 135 | glycosphingolipid catabolic process (GO:0046479) | 2.72797182 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.47327334 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.04863684 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.18925672 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 5.42263926 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.97439154 |
| 6 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.20124543 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.19947279 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.53193342 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.28303442 |
| 10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.21940402 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.04734988 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.83906850 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.82402108 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.71254459 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.56468896 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.46006179 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.32990310 |
| 18 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.30714376 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.30294764 |
| 20 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.27148740 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.22745210 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.15005262 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 2.07450106 |
| 24 | PU_27001747_Chip-Seq_BMDM_Mouse | 2.07050384 |
| 25 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.06657980 |
| 26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.06071934 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.97840374 |
| 28 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.95362084 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.85899178 |
| 30 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.79948932 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.78160251 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.77439735 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.75891326 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.65982212 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.64924963 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.61892946 |
| 37 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55717589 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52311227 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.47640969 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.44566229 |
| 41 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.43449193 |
| 42 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.42224082 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41918944 |
| 44 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.40397400 |
| 45 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.39034027 |
| 46 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.37154292 |
| 47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.34379087 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34347163 |
| 49 | MAF_26560356_Chip-Seq_TH1_Human | 1.30411175 |
| 50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26063465 |
| 51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.20812926 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20611127 |
| 53 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18557586 |
| 54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.13938824 |
| 55 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13782262 |
| 56 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13673301 |
| 57 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.13522596 |
| 58 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.13501573 |
| 59 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11823344 |
| 60 | MAF_26560356_Chip-Seq_TH2_Human | 1.10159225 |
| 61 | MYB_26560356_Chip-Seq_TH1_Human | 1.09756493 |
| 62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08465593 |
| 63 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06278671 |
| 64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03431822 |
| 65 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02549738 |
| 66 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02413295 |
| 67 | MYC_22102868_ChIP-Seq_BL_Human | 1.02284633 |
| 68 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.99863663 |
| 69 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98508894 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96910977 |
| 71 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96657891 |
| 72 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96544250 |
| 73 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.95153340 |
| 74 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94311717 |
| 75 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.93838210 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.93681019 |
| 77 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92549425 |
| 78 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90367047 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89526271 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88685300 |
| 81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87386136 |
| 82 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87115654 |
| 83 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.86980944 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86672041 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85926873 |
| 86 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84421249 |
| 87 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83362990 |
| 88 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82810055 |
| 89 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.82383320 |
| 90 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.81859799 |
| 91 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.81810850 |
| 92 | UTX_26944678_Chip-Seq_JUKART_Human | 0.81718816 |
| 93 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.81453551 |
| 94 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.81177185 |
| 95 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79759645 |
| 96 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79084001 |
| 97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78733636 |
| 98 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78733636 |
| 99 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78141421 |
| 100 | CJUN_26792858_Chip-Seq_BT549_Human | 0.77626060 |
| 101 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.76871068 |
| 102 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.76368758 |
| 103 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.73261335 |
| 104 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.71851417 |
| 105 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.71329524 |
| 106 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.70740958 |
| 107 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.70586798 |
| 108 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70110616 |
| 109 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69612691 |
| 110 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.69392679 |
| 111 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.68725389 |
| 112 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.68159549 |
| 113 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.67822733 |
| 114 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.67482850 |
| 115 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.67110757 |
| 116 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.64245400 |
| 117 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.63117186 |
| 118 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.62998991 |
| 119 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.62523672 |
| 120 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.61746195 |
| 121 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.60848824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 5.05067994 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.28020368 |
| 3 | MP0003436_decreased_susceptibility_to | 3.81353064 |
| 4 | MP0006082_CNS_inflammation | 3.70595456 |
| 5 | MP0003303_peritoneal_inflammation | 3.64199983 |
| 6 | MP0003172_abnormal_lysosome_physiology | 3.49599572 |
| 7 | * MP0002419_abnormal_innate_immunity | 3.18860127 |
| 8 | * MP0002148_abnormal_hypersensitivity_rea | 2.98611703 |
| 9 | * MP0005000_abnormal_immune_tolerance | 2.82800110 |
| 10 | MP0009840_abnormal_foam_cell | 2.77922359 |
| 11 | MP0009785_altered_susceptibility_to | 2.62888723 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.61042411 |
| 13 | MP0003690_abnormal_glial_cell | 2.53811878 |
| 14 | MP0005025_abnormal_response_to | 2.49219445 |
| 15 | * MP0002452_abnormal_antigen_presenting | 2.45759845 |
| 16 | MP0005464_abnormal_platelet_physiology | 2.32874827 |
| 17 | MP0000604_amyloidosis | 2.31647481 |
| 18 | MP0001533_abnormal_skeleton_physiology | 2.29061939 |
| 19 | * MP0001800_abnormal_humoral_immune | 2.21864382 |
| 20 | * MP0002723_abnormal_immune_serum | 2.20489090 |
| 21 | * MP0001790_abnormal_immune_system | 2.18760237 |
| 22 | * MP0005387_immune_system_phenotype | 2.18760237 |
| 23 | MP0005671_abnormal_response_to | 2.09399360 |
| 24 | MP0003724_increased_susceptibility_to | 2.08255223 |
| 25 | MP0000569_abnormal_digit_pigmentation | 2.01586878 |
| 26 | MP0004510_myositis | 1.98870109 |
| 27 | * MP0001819_abnormal_immune_cell | 1.96623427 |
| 28 | * MP0002420_abnormal_adaptive_immunity | 1.95248159 |
| 29 | MP0003075_altered_response_to | 1.94163625 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.92403662 |
| 31 | MP0000343_altered_response_to | 1.91247052 |
| 32 | MP0005310_abnormal_salivary_gland | 1.84654032 |
| 33 | MP0005257_abnormal_intraocular_pressure | 1.82636766 |
| 34 | MP0000685_abnormal_immune_system | 1.82302446 |
| 35 | MP0002405_respiratory_system_inflammati | 1.79497098 |
| 36 | MP0003448_altered_tumor_morphology | 1.78975430 |
| 37 | * MP0001845_abnormal_inflammatory_respons | 1.65790244 |
| 38 | MP0010307_abnormal_tumor_latency | 1.62161351 |
| 39 | MP0002998_abnormal_bone_remodeling | 1.61686405 |
| 40 | MP0004947_skin_inflammation | 1.57449071 |
| 41 | MP0003828_pulmonary_edema | 1.53457051 |
| 42 | * MP0008469_abnormal_protein_level | 1.51401172 |
| 43 | MP0001853_heart_inflammation | 1.51117472 |
| 44 | MP0005166_decreased_susceptibility_to | 1.46023341 |
| 45 | MP0009764_decreased_sensitivity_to | 1.42991372 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.38705994 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.36241224 |
| 48 | MP0005451_abnormal_body_composition | 1.34788082 |
| 49 | MP0008438_abnormal_cutaneous_collagen | 1.34563062 |
| 50 | MP0002139_abnormal_hepatobiliary_system | 1.33343445 |
| 51 | * MP0000716_abnormal_immune_system | 1.33186137 |
| 52 | MP0008260_abnormal_autophagy | 1.33179251 |
| 53 | MP0005167_abnormal_blood-brain_barrier | 1.32913672 |
| 54 | MP0003806_abnormal_nucleotide_metabolis | 1.29688787 |
| 55 | MP0000689_abnormal_spleen_morphology | 1.29526051 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.26105070 |
| 57 | MP0009278_abnormal_bone_marrow | 1.20278931 |
| 58 | MP0001851_eye_inflammation | 1.18156437 |
| 59 | MP0000858_altered_metastatic_potential | 1.17794228 |
| 60 | MP0005174_abnormal_tail_pigmentation | 1.16901137 |
| 61 | * MP0002398_abnormal_bone_marrow | 1.15787173 |
| 62 | MP0008004_abnormal_stomach_pH | 1.14695421 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.13752072 |
| 64 | MP0005390_skeleton_phenotype | 1.08680678 |
| 65 | * MP0002429_abnormal_blood_cell | 1.06333273 |
| 66 | MP0000015_abnormal_ear_pigmentation | 1.04990494 |
| 67 | MP0002933_joint_inflammation | 1.04448770 |
| 68 | MP0005164_abnormal_response_to | 1.04073460 |
| 69 | MP0002722_abnormal_immune_system | 1.03826527 |
| 70 | MP0003566_abnormal_cell_adhesion | 1.02174192 |
| 71 | MP0003329_amyloid_beta_deposits | 1.02141322 |
| 72 | MP0002396_abnormal_hematopoietic_system | 0.98945545 |
| 73 | MP0002090_abnormal_vision | 0.98276945 |
| 74 | MP0003763_abnormal_thymus_physiology | 0.96201422 |
| 75 | MP0006054_spinal_hemorrhage | 0.96076522 |
| 76 | MP0002166_altered_tumor_susceptibility | 0.94455418 |
| 77 | MP0005076_abnormal_cell_differentiation | 0.92847149 |
| 78 | MP0004883_abnormal_blood_vessel | 0.91490435 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 0.91447114 |
| 80 | MP0000249_abnormal_blood_vessel | 0.90101677 |
| 81 | MP0002254_reproductive_system_inflammat | 0.89877372 |
| 82 | MP0005197_abnormal_uvea_morphology | 0.88486922 |
| 83 | MP0004782_abnormal_surfactant_physiolog | 0.86844544 |
| 84 | MP0003795_abnormal_bone_structure | 0.84946243 |
| 85 | MP0005397_hematopoietic_system_phenotyp | 0.84573593 |
| 86 | MP0001545_abnormal_hematopoietic_system | 0.84573593 |
| 87 | MP0000371_diluted_coat_color | 0.78459334 |
| 88 | MP0001663_abnormal_digestive_system | 0.77534759 |
| 89 | MP0000767_abnormal_smooth_muscle | 0.77282275 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.76907153 |
| 91 | MP0002877_abnormal_melanocyte_morpholog | 0.75980341 |
| 92 | MP0003866_abnormal_defecation | 0.73907385 |
| 93 | * MP0009763_increased_sensitivity_to | 0.72884916 |
| 94 | MP0002006_tumorigenesis | 0.71879255 |
| 95 | MP0001915_intracranial_hemorrhage | 0.71142652 |
| 96 | MP0005165_increased_susceptibility_to | 0.69165284 |
| 97 | MP0003279_aneurysm | 0.69063945 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.68778394 |
| 99 | MP0003045_fibrosis | 0.68358344 |
| 100 | * MP0000920_abnormal_myelination | 0.67518618 |
| 101 | MP0005365_abnormal_bile_salt | 0.65861938 |
| 102 | MP0000490_abnormal_crypts_of | 0.65401476 |
| 103 | MP0005083_abnormal_biliary_tract | 0.65257533 |
| 104 | MP0003634_abnormal_glial_cell | 0.65148769 |
| 105 | MP0002138_abnormal_hepatobiliary_system | 0.64826928 |
| 106 | MP0004130_abnormal_muscle_cell | 0.63410333 |
| 107 | MP0008874_decreased_physiological_sensi | 0.62519409 |
| 108 | MP0002332_abnormal_exercise_endurance | 0.61347151 |
| 109 | MP0001958_emphysema | 0.60352456 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.60085827 |
| 111 | MP0001873_stomach_inflammation | 0.59921017 |
| 112 | MP0002132_abnormal_respiratory_system | 0.59060372 |
| 113 | MP0001542_abnormal_bone_strength | 0.58921321 |
| 114 | MP0005171_absent_coat_pigmentation | 0.57029256 |
| 115 | MP0004808_abnormal_hematopoietic_stem | 0.56849650 |
| 116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.56672025 |
| 117 | MP0005319_abnormal_enzyme/_coenzyme | 0.56026801 |
| 118 | MP0003195_calcinosis | 0.55349027 |
| 119 | MP0003091_abnormal_cell_migration | 0.55025870 |
| 120 | MP0000703_abnormal_thymus_morphology | 0.53739275 |
| 121 | MP0003705_abnormal_hypodermis_morpholog | 0.52699387 |
| 122 | MP0003633_abnormal_nervous_system | 0.48871499 |
| 123 | MP0009115_abnormal_fat_cell | 0.48232835 |
| 124 | * MP0000609_abnormal_liver_physiology | 0.47780891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 7.90892027 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 6.63343249 |
| 3 | Recurrent abscess formation (HP:0002722) | 6.60569742 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 6.33656210 |
| 5 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 6.02563798 |
| 6 | Glomerulonephritis (HP:0000099) | 5.94396829 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 5.71932826 |
| 8 | Eczematoid dermatitis (HP:0000976) | 5.44222437 |
| 9 | Dysostosis multiplex (HP:0000943) | 4.87985880 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 4.75338809 |
| 11 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.75338809 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.75338809 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.74304372 |
| 14 | Abnormality of macrophages (HP:0004311) | 4.70502074 |
| 15 | Disinhibition (HP:0000734) | 4.68708229 |
| 16 | Complement deficiency (HP:0004431) | 4.44108028 |
| 17 | Axonal loss (HP:0003447) | 4.33424138 |
| 18 | Abnormality of complement system (HP:0005339) | 4.04867612 |
| 19 | Mucopolysacchariduria (HP:0008155) | 3.88611576 |
| 20 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.88611576 |
| 21 | Thick nail (HP:0001805) | 3.83405689 |
| 22 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.78815416 |
| 23 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.73699625 |
| 24 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.73699625 |
| 25 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.73699625 |
| 26 | Agnosia (HP:0010524) | 3.73648743 |
| 27 | Prostate neoplasm (HP:0100787) | 3.67453131 |
| 28 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.44949250 |
| 29 | Nephritis (HP:0000123) | 3.32320882 |
| 30 | Gingivitis (HP:0000230) | 3.29686681 |
| 31 | Myocardial infarction (HP:0001658) | 3.28645285 |
| 32 | Recurrent skin infections (HP:0001581) | 3.24638787 |
| 33 | Chronic obstructive pulmonary disease (HP:0006510) | 3.24131432 |
| 34 | Obstructive lung disease (HP:0006536) | 3.24131432 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 3.23030313 |
| 36 | Myositis (HP:0100614) | 3.21111694 |
| 37 | Orchitis (HP:0100796) | 3.13676728 |
| 38 | Upper motor neuron abnormality (HP:0002127) | 3.13174137 |
| 39 | Pustule (HP:0200039) | 3.12647645 |
| 40 | Amyloidosis (HP:0011034) | 2.96743782 |
| 41 | Basal ganglia calcification (HP:0002135) | 2.89701275 |
| 42 | Loss of speech (HP:0002371) | 2.84582253 |
| 43 | Optic neuritis (HP:0100653) | 2.84045870 |
| 44 | Retrobulbar optic neuritis (HP:0100654) | 2.84045870 |
| 45 | Hemoptysis (HP:0002105) | 2.83330046 |
| 46 | Hematochezia (HP:0002573) | 2.80356359 |
| 47 | Autoimmune thrombocytopenia (HP:0001973) | 2.79936506 |
| 48 | Pathologic fracture (HP:0002756) | 2.77449261 |
| 49 | Purpura (HP:0000979) | 2.72233339 |
| 50 | Keratoconjunctivitis sicca (HP:0001097) | 2.72115273 |
| 51 | Spontaneous hematomas (HP:0007420) | 2.70945497 |
| 52 | J-shaped sella turcica (HP:0002680) | 2.69126714 |
| 53 | Hepatosplenomegaly (HP:0001433) | 2.68587207 |
| 54 | T lymphocytopenia (HP:0005403) | 2.66529794 |
| 55 | Increased serum ferritin (HP:0003281) | 2.62598003 |
| 56 | Recurrent fungal infections (HP:0002841) | 2.57825347 |
| 57 | Inappropriate behavior (HP:0000719) | 2.53890493 |
| 58 | Abnormality of T cell number (HP:0011839) | 2.52848887 |
| 59 | Progressive visual loss (HP:0000529) | 2.52039529 |
| 60 | Gastrointestinal infarctions (HP:0005244) | 2.47545362 |
| 61 | Keratoconjunctivitis (HP:0001096) | 2.47488201 |
| 62 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.45817003 |
| 63 | Stomatitis (HP:0010280) | 2.42214031 |
| 64 | Cellulitis (HP:0100658) | 2.39700366 |
| 65 | Osteolytic defects of the hand bones (HP:0009699) | 2.38166883 |
| 66 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.38166883 |
| 67 | Premature loss of primary teeth (HP:0006323) | 2.37634045 |
| 68 | Retinal atrophy (HP:0001105) | 2.36243168 |
| 69 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.35834005 |
| 70 | Mutism (HP:0002300) | 2.35763392 |
| 71 | Peripheral demyelination (HP:0011096) | 2.35065009 |
| 72 | Encephalitis (HP:0002383) | 2.34903532 |
| 73 | Periodontitis (HP:0000704) | 2.31659077 |
| 74 | Apathy (HP:0000741) | 2.28300970 |
| 75 | Abnormality of the lumbar spine (HP:0100712) | 2.28272972 |
| 76 | Osteomyelitis (HP:0002754) | 2.27590050 |
| 77 | Diminished motivation (HP:0000745) | 2.27093404 |
| 78 | Recurrent pneumonia (HP:0006532) | 2.26218457 |
| 79 | Conjunctival telangiectasia (HP:0000524) | 2.25487974 |
| 80 | Recurrent viral infections (HP:0004429) | 2.25436327 |
| 81 | Bone pain (HP:0002653) | 2.23633907 |
| 82 | Urticaria (HP:0001025) | 2.22569842 |
| 83 | Abnormality of iron homeostasis (HP:0011031) | 2.22060828 |
| 84 | Arterial tortuosity (HP:0005116) | 2.21612840 |
| 85 | Increased IgM level (HP:0003496) | 2.21521300 |
| 86 | Tetraparesis (HP:0002273) | 2.19850364 |
| 87 | Polyneuropathy (HP:0001271) | 2.18434776 |
| 88 | Gangrene (HP:0100758) | 2.17400344 |
| 89 | Thoracic kyphosis (HP:0002942) | 2.16046053 |
| 90 | Personality changes (HP:0000751) | 2.14228478 |
| 91 | Pulmonary embolism (HP:0002204) | 2.12447302 |
| 92 | Chest pain (HP:0100749) | 2.11437158 |
| 93 | Nuclear cataract (HP:0100018) | 2.10914278 |
| 94 | Neuronal loss in central nervous system (HP:0002529) | 2.09399238 |
| 95 | Malnutrition (HP:0004395) | 2.08810470 |
| 96 | Epistaxis (HP:0000421) | 2.08676191 |
| 97 | Neurofibrillary tangles (HP:0002185) | 2.05077615 |
| 98 | Episodic fever (HP:0001954) | 2.04601469 |
| 99 | Pulmonary infiltrates (HP:0002113) | 2.04048272 |
| 100 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.02685622 |
| 101 | Abnormality of the prostate (HP:0008775) | 2.02136161 |
| 102 | Vasculitis (HP:0002633) | 1.99920705 |
| 103 | Joint hemorrhage (HP:0005261) | 1.98937079 |
| 104 | Progressive neurologic deterioration (HP:0002344) | 1.97854217 |
| 105 | Arterial thrombosis (HP:0004420) | 1.97250064 |
| 106 | Cerebral inclusion bodies (HP:0100314) | 1.96742916 |
| 107 | Anorexia (HP:0002039) | 1.95279666 |
| 108 | Leukocytosis (HP:0001974) | 1.93139830 |
| 109 | Petechiae (HP:0000967) | 1.92589688 |
| 110 | Gingival bleeding (HP:0000225) | 1.90566897 |
| 111 | Vertebral compression fractures (HP:0002953) | 1.90405013 |
| 112 | Memory impairment (HP:0002354) | 1.90279882 |
| 113 | Increased IgE level (HP:0003212) | 1.89692274 |
| 114 | Vascular tortuosity (HP:0004948) | 1.89303467 |
| 115 | Abnormality of the pleura (HP:0002103) | 1.86979011 |
| 116 | Hypergammaglobulinemia (HP:0010702) | 1.86221726 |
| 117 | Asymmetric septal hypertrophy (HP:0001670) | 1.83629385 |
| 118 | Spinal muscular atrophy (HP:0007269) | 1.83598361 |
| 119 | Increased CSF protein (HP:0002922) | 1.83432834 |
| 120 | Meningitis (HP:0001287) | 1.79910242 |
| 121 | Colitis (HP:0002583) | 1.79494724 |
| 122 | Recurrent lower respiratory tract infections (HP:0002783) | 1.76516157 |
| 123 | Eosinophilia (HP:0001880) | 1.74463711 |
| 124 | Interstitial pulmonary disease (HP:0006530) | 1.74391465 |
| 125 | Hypercholesterolemia (HP:0003124) | 1.73812048 |
| 126 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.72231370 |
| 127 | Recurrent cutaneous fungal infections (HP:0011370) | 1.72231370 |
| 128 | Impaired platelet aggregation (HP:0003540) | 1.71734076 |
| 129 | Abnormal platelet function (HP:0011869) | 1.71734076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.38472610 |
| 2 | TGFBR2 | 4.08152986 |
| 3 | KIT | 3.37384479 |
| 4 | IRAK4 | 3.35633407 |
| 5 | TYK2 | 3.27944432 |
| 6 | RIPK4 | 3.21934981 |
| 7 | MAP3K14 | 3.12419820 |
| 8 | TBK1 | 2.99637660 |
| 9 | GRK7 | 2.87279154 |
| 10 | IRAK3 | 2.72729802 |
| 11 | NEK9 | 2.47583427 |
| 12 | MAP4K1 | 2.10591186 |
| 13 | IKBKB | 1.93702369 |
| 14 | IKBKE | 1.93662529 |
| 15 | ERN1 | 1.87388314 |
| 16 | JAK1 | 1.85968163 |
| 17 | CSF1R | 1.82718432 |
| 18 | PRPF4B | 1.76540063 |
| 19 | CAMK1D | 1.69955810 |
| 20 | HCK | 1.66487116 |
| 21 | ZAP70 | 1.65081121 |
| 22 | TAOK3 | 1.59457326 |
| 23 | CSK | 1.54208973 |
| 24 | STK10 | 1.53253736 |
| 25 | FES | 1.51868231 |
| 26 | TXK | 1.50412368 |
| 27 | LYN | 1.50271858 |
| 28 | SYK | 1.47627446 |
| 29 | TAOK1 | 1.44814148 |
| 30 | PBK | 1.44366936 |
| 31 | ITK | 1.43874142 |
| 32 | TAOK2 | 1.42816813 |
| 33 | BTK | 1.33221100 |
| 34 | DDR2 | 1.29908437 |
| 35 | MAP3K13 | 1.27875857 |
| 36 | LCK | 1.27813000 |
| 37 | JAK3 | 1.24450593 |
| 38 | EPHB1 | 1.21899886 |
| 39 | PIM2 | 1.21472746 |
| 40 | FGR | 1.19420196 |
| 41 | MOS | 1.18035189 |
| 42 | SCYL2 | 1.16643426 |
| 43 | ACVR1B | 1.14124388 |
| 44 | JAK2 | 1.13924074 |
| 45 | TNK2 | 1.13748548 |
| 46 | MAP3K1 | 1.12838358 |
| 47 | CDC42BPA | 1.10638475 |
| 48 | MATK | 1.07500802 |
| 49 | CAMK1G | 1.07460606 |
| 50 | TEC | 1.07061526 |
| 51 | TESK2 | 1.03747658 |
| 52 | CAMKK2 | 1.03043817 |
| 53 | TTN | 0.99238116 |
| 54 | SIK2 | 0.98894805 |
| 55 | CHUK | 0.97649385 |
| 56 | ADRBK2 | 0.95752600 |
| 57 | EGFR | 0.93783843 |
| 58 | YES1 | 0.92520785 |
| 59 | CDK6 | 0.91740214 |
| 60 | SIK3 | 0.89701115 |
| 61 | PLK2 | 0.88949937 |
| 62 | NME2 | 0.88728101 |
| 63 | MAP2K3 | 0.82589057 |
| 64 | BMPR2 | 0.81945607 |
| 65 | PDK2 | 0.77803959 |
| 66 | DAPK2 | 0.77148274 |
| 67 | MARK3 | 0.77113713 |
| 68 | GRK6 | 0.76938699 |
| 69 | EIF2AK2 | 0.76593508 |
| 70 | PRKCD | 0.73395469 |
| 71 | PDPK1 | 0.71105306 |
| 72 | CLK1 | 0.69797664 |
| 73 | ABL1 | 0.67793512 |
| 74 | FGFR3 | 0.66248069 |
| 75 | CAMKK1 | 0.66209294 |
| 76 | RPS6KA4 | 0.64791669 |
| 77 | PIM1 | 0.62157710 |
| 78 | TRPM7 | 0.61407397 |
| 79 | KSR2 | 0.60904148 |
| 80 | MAP3K3 | 0.58720574 |
| 81 | PAK4 | 0.57771012 |
| 82 | STK4 | 0.56434519 |
| 83 | FYN | 0.55525504 |
| 84 | ABL2 | 0.55366833 |
| 85 | MAPKAPK2 | 0.54515562 |
| 86 | RIPK1 | 0.52993789 |
| 87 | MARK2 | 0.52275938 |
| 88 | MAP3K6 | 0.51801884 |
| 89 | STK3 | 0.49959613 |
| 90 | MAP2K6 | 0.49912964 |
| 91 | IGF1R | 0.49695881 |
| 92 | FGFR4 | 0.46061551 |
| 93 | IRAK2 | 0.44079218 |
| 94 | PIK3CG | 0.42065413 |
| 95 | MAP3K11 | 0.41027711 |
| 96 | MAPK7 | 0.39982260 |
| 97 | PKN2 | 0.39532543 |
| 98 | PTK6 | 0.39417092 |
| 99 | NUAK1 | 0.39050976 |
| 100 | EPHA3 | 0.39030836 |
| 101 | ERBB3 | 0.37988768 |
| 102 | PRKD2 | 0.37504288 |
| 103 | ARAF | 0.35188636 |
| 104 | MAP3K5 | 0.34854361 |
| 105 | PDGFRB | 0.33846633 |
| 106 | IRAK1 | 0.32761787 |
| 107 | BMX | 0.32689172 |
| 108 | CDK12 | 0.32494730 |
| 109 | PRKG2 | 0.30881696 |
| 110 | RPS6KA2 | 0.30667969 |
| 111 | KSR1 | 0.30532681 |
| 112 | RPS6KA6 | 0.30240631 |
| 113 | SRC | 0.30120398 |
| 114 | MAPK4 | 0.29515302 |
| 115 | PRKCQ | 0.29511921 |
| 116 | GSK3A | 0.29220068 |
| 117 | MAPK12 | 0.27737491 |
| 118 | MAP3K2 | 0.27556752 |
| 119 | RPS6KL1 | 0.26328447 |
| 120 | RPS6KC1 | 0.26328447 |
| 121 | PDK1 | 0.25901035 |
| 122 | INSR | 0.24791428 |
| 123 | PRKG1 | 0.20902719 |
| 124 | DMPK | 0.20887398 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.34114654 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.82956743 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 3.81008874 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.14480408 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 3.03088891 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.77557384 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.73521200 |
| 8 | Pertussis_Homo sapiens_hsa05133 | 2.58404991 |
| 9 | Phagosome_Homo sapiens_hsa04145 | 2.35755666 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 2.30991447 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.00002340 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.97323275 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.93082826 |
| 14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.91469609 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.89061260 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.87127459 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.87072085 |
| 18 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.75418619 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.66170316 |
| 20 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.60838792 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.59842446 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.57609323 |
| 23 | Salmonella infection_Homo sapiens_hsa05132 | 1.55404637 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.48425832 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.42112212 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.42046161 |
| 27 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.38370347 |
| 28 | Apoptosis_Homo sapiens_hsa04210 | 1.33359533 |
| 29 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.32715948 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29010214 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23832602 |
| 32 | Prion diseases_Homo sapiens_hsa05020 | 1.22930749 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.19081604 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.17934060 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14505571 |
| 36 | Asthma_Homo sapiens_hsa05310 | 1.12747529 |
| 37 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.12286582 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.10417892 |
| 39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.08638509 |
| 40 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.06384365 |
| 41 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.04363206 |
| 42 | Allograft rejection_Homo sapiens_hsa05330 | 1.04267170 |
| 43 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.02944513 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01780551 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.00179516 |
| 46 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00002331 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.96023277 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.94438488 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92934198 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89819245 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.87489427 |
| 52 | Amoebiasis_Homo sapiens_hsa05146 | 0.83585964 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.83288759 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81923558 |
| 55 | Mineral absorption_Homo sapiens_hsa04978 | 0.79641420 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79343108 |
| 57 | Endocytosis_Homo sapiens_hsa04144 | 0.79251886 |
| 58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.78464967 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.75352492 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73908350 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.73874514 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73197488 |
| 63 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68448924 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67695060 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65123444 |
| 66 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63320510 |
| 67 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62522352 |
| 68 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58649303 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51665666 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51597123 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.51373066 |
| 72 | Bladder cancer_Homo sapiens_hsa05219 | 0.51118866 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49882161 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.48827880 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47326299 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45937487 |
| 77 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.42586408 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42049266 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41914723 |
| 80 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.41736258 |
| 81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40448535 |
| 82 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39719224 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37651458 |
| 84 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35519677 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35270635 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34137621 |
| 87 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.33808202 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33722048 |
| 89 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.32513606 |
| 90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31947305 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29294945 |
| 92 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.28631380 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28580439 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.27682717 |
| 95 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.26911605 |
| 96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.26693076 |
| 97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.26540250 |
| 98 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.26459401 |
| 99 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.25985829 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.25893705 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.23642059 |
| 102 | Glioma_Homo sapiens_hsa05214 | 0.22526567 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21732903 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.20846417 |
| 105 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.20400487 |
| 106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.20260142 |
| 107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.19481818 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.18894314 |
| 109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.18792669 |
| 110 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.15250177 |
| 111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.14952952 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.14716293 |

